Related references
Note: Only part of the references are listed.2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site
Benoit Bestgen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action
Benoit Bestgen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Shaoyong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment
Ke Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders
Mark E. Gurney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Novel non-ATP competitive small molecules targeting the CK2 α/β interface
Paul Brear et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Second-generation CK2α inhibitors targeting the αD pocket
Jessica Iegre et al.
CHEMICAL SCIENCE (2018)
Identification of a cellularly active SIRT6 allosteric activator
Zhimin Huang et al.
NATURE CHEMICAL BIOLOGY (2018)
A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods
Hai-ming Jiang et al.
ACTA PHARMACOLOGICA SINICA (2017)
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066
Claudia De Fusco et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Casein kinases as potential therapeutic targets
Giorgio Cozza et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Alloscore: a method for predicting allosteric ligand-protein interactions
Shuai Li et al.
BIOINFORMATICS (2016)
Emerging Computational Methods for the Rational Discovery of Allosteric Drugs
Jeffrey R. Wagner et al.
CHEMICAL REVIEWS (2016)
A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
Hyeongki Kim et al.
DISEASE MODELS & MECHANISMS (2016)
Specific inhibition of CK2 alpha from an anchor outside the active site
Paul Brear et al.
CHEMICAL SCIENCE (2016)
Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library
Barbara Guerra et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Enhancing the anticancer effects of 5-fluorouracil: Current challenges and future perspectives
Francois Ghiringhelli et al.
BIOMEDICAL JOURNAL (2015)
Drugs for Allosteric Sites on Receptors
Cody J. Wenthur et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Inhibiting Helicobacter pylori HtrA protease by addressing a computationally predicted allosteric ligand binding site
Anna Maria Perna et al.
CHEMICAL SCIENCE (2014)
Kinase CK2 Inhibition: An Update
G. Cozza et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Activity-based kinase profiling of approved tyrosine kinase inhibitors
Daisuke Kitagawa et al.
GENES TO CELLS (2013)
Inhibition of CK2: An Attractive Therapeutic Target for Cancer Treatment
Ahmed F. Abdel-Magid
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2
Shu Liu et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
Protein kinase CK2 inhibitors: a patent review
Giorgio Cozza et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer
Roberto Battistutta et al.
BIOCHEMISTRY (2011)
How Druggable Is Protein Kinase CK2?
Giorgio Cozza et al.
MEDICINAL RESEARCH REVIEWS (2010)
ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for Kinases
Hicham Zegzouti et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2009)
Searching for new allosteric sites in enzymes
JA Hardy et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2004)
Share Paper
